TreeWAS – Variant ID: rs2389438

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G93.8 Other specified disorders of brain	0.000	0.974	0.026
G93 Other disorders of brain	0.000	0.974	0.026
G93.3 Postviral fatigue syndrome	0.000	0.977	0.023
G90-G99 Other disorders of the nervous system	0.000	0.978	0.022
K22.9 Disease of oesophagus, unspecified	0.022	0.978	0.000
G93.2 Benign intracranial hypertension	0.000	0.978	0.022
G91 Hydrocephalus	0.000	0.978	0.022
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.979	0.021
G96 Other disorders of central nervous system	0.000	0.979	0.021
G91.9 Hydrocephalus, unspecified	0.000	0.980	0.020
G96.0 Cerebrospinal fluid leak	0.000	0.980	0.020
R22.4 Localised swelling, mass and lump, lower limb	0.020	0.980	0.000
G93.9 Disorder of brain, unspecified	0.000	0.981	0.019
G90 Disorders of autonomic nervous system	0.000	0.981	0.019
G93.7 Reye's syndrome	0.000	0.981	0.018
G91.2 Normal-pressure hydrocephalus	0.000	0.982	0.018
G93.5 Compression of brain	0.000	0.982	0.018
G93.4 Encephalopathy, unspecified	0.000	0.982	0.018
G91.1 Obstructive hydrocephalus	0.000	0.983	0.017
G95 Other diseases of spinal cord	0.000	0.983	0.017
G95.2 Cord compression, unspecified	0.000	0.983	0.017
G93.0 Cerebral cysts	0.000	0.983	0.017
G92 Toxic encephalopathy	0.000	0.984	0.016
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.984	0.016
G91.8 Other hydrocephalus	0.000	0.984	0.016
G99 Other disorders of nervous system in diseases classified elsewhere	0.000	0.984	0.016
G98 Other disorders of nervous system, not elsewhere classified	0.000	0.985	0.015
G96.8 Other specified disorders of central nervous system	0.000	0.985	0.015
G90.9 Disorder of autonomic nervous system, unspecified	0.000	0.985	0.015
G96.9 Disorder of central nervous system, unspecified	0.000	0.985	0.015
G90.2 Horner's syndrome	0.000	0.985	0.015
G93.6 Cerebral oedema	0.000	0.985	0.015
G90.3 Multisystem degeneration	0.000	0.985	0.015
Z45.0 Adjustment and management of cardiac pacemaker	0.000	0.985	0.015
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.000	0.986	0.014
G90.4 Autonomic dysreflexia	0.000	0.986	0.014
G90.1 Familial dysautonomia [Riley-Day]	0.000	0.986	0.014
G91.0 Communicating hydrocephalus	0.000	0.987	0.013
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.987	0.013
G96.1 Disorders of meninges, not elsewhere classified	0.000	0.987	0.013
G90.0 Idiopathic peripheral autonomic neuropathy	0.000	0.987	0.013
G90.8 Other disorders of autonomic nervous system	0.000	0.987	0.012
G95.1 Vascular myelopathies	0.000	0.988	0.012
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.000	0.988	0.011
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.000	0.988	0.011
G95.0 Syringomyelia and syringobulbia	0.000	0.989	0.011
G97.1 Other reaction to spinal and lumbar puncture	0.000	0.989	0.011
G97.9 Postprocedural disorder of nervous system, unspecified	0.000	0.989	0.010
G97.2 Intracranial hypotension following ventricular shunting	0.000	0.989	0.010
G94 Other disorders of brain in diseases classified elsewhere	0.001	0.990	0.010
G97.0 Cerebrospinal fluid leak from spinal puncture	0.000	0.990	0.010
G95.9 Disease of spinal cord, unspecified	0.000	0.990	0.010
G95.8 Other specified diseases of spinal cord	0.000	0.991	0.009
G97.8 Other postprocedural disorders of nervous system	0.000	0.991	0.008
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.001	0.992	0.007
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.001	0.992	0.007
K56.6 Other and unspecified intestinal obstruction	0.000	0.992	0.008
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.000	0.993	0.007
N05.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
K62.6 Ulcer of anus and rectum	0.000	0.994	0.006
G94.2 Hydrocephalus in other diseases classified elsewhere	0.001	0.994	0.005
G94.1 Hydrocephalus in neoplastic disease	0.001	0.994	0.005
T40.4 Other synthetic narcotics	0.005	0.995	0.000
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
N05 Unspecified nephritic syndrome	0.005	0.995	0.000
T40.2 Other opioids	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
D62 Acute posthaemorrhagic anaemia	0.004	0.996	0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.000	0.996	0.004
L72.1 Trichilemmal cyst	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
N02.9 Unspecified	0.004	0.996	0.000
R04.2 Haemoptysis	0.000	0.996	0.004
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.996	0.000
T40.8 Lysergide [LSD]	0.004	0.996	0.000
T40.7 Cannabis (derivatives)	0.004	0.996	0.000
T40.5 Cocaine	0.004	0.996	0.000
T40.3 Methadone	0.004	0.996	0.000
T40.1 Heroin	0.004	0.996	0.000
T40.0 Opium	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
I49.4 Other and unspecified premature depolarisation	0.000	0.996	0.004
N05.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
N05.9 Unspecified	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
N05.6 Dense deposit disease	0.004	0.996	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N05.0 Minor glomerular abnormality	0.004	0.996	0.000
N05.8 Other	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
W55.8 Other specified place	0.004	0.996	0.000
N02 Recurrent and persistent haematuria	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
N05.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
N04 Nephrotic syndrome	0.004	0.996	0.000
W55 Bitten or struck by other mammals	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
N04.9 Unspecified	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.996	0.000
N00-N08 Glomerular diseases	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.996	0.000
N90.6 Hypertrophy of vulva	0.004	0.996	0.000
T39.0 Salicylates	0.003	0.997	0.000
N02.0 Minor glomerular abnormality	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
O42.9 Premature rupture of membranes, unspecified	0.003	0.997	0.000
W55.0 Home	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
W55.7 Farm	0.003	0.997	0.000
N02.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
W55.4 Street and highway	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
N04.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.003	0.997	0.000
N04.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
E14.3 With ophthalmic complications	0.003	0.997	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N02.6 Dense deposit disease	0.003	0.997	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N02.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
C44.5 Skin of trunk	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
N04.8 Other	0.003	0.997	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N04.6 Dense deposit disease	0.003	0.997	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N04.0 Minor glomerular abnormality	0.003	0.997	0.000
W55.9 Unspecified place	0.003	0.997	0.000
W55.5 Trade and service area	0.003	0.997	0.000
W55.6 Industrial and construction area	0.003	0.997	0.000
W55.3 Sports and athletics area	0.003	0.997	0.000
W55.2 School, other institution and public administrative area	0.003	0.997	0.000
W55.1 Residential institution	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
Z94.0 Kidney transplant status	0.003	0.997	0.000
S62.61 Fracture of other finger (open)	0.003	0.997	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.003	0.997	0.000
N06 Isolated proteinuria with specified morphological lesion	0.003	0.997	0.000
N01 Rapidly progressive nephritic syndrome	0.003	0.997	0.000
N00 Acute nephritic syndrome	0.003	0.997	0.000
H33.2 Serous retinal detachment	0.000	0.997	0.003
T42.1 Iminostilbenes	0.003	0.997	0.000
I73.9 Peripheral vascular disease, unspecified	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.997	0.000
T42.3 Barbiturates	0.002	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.997	0.000
L72 Follicular cysts of skin and subcutaneous tissue	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.997	0.000
R25.1 Tremor, unspecified	0.003	0.997	0.000
F02.0 Dementia in Pick's disease	0.003	0.997	0.000
N60.1 Diffuse cystic mastopathy	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
N62 Hypertrophy of breast	0.002	0.998	0.000
O03.9 Complete or unspecified, without complication	0.000	0.998	0.002
N39.3 Stress incontinence	0.002	0.998	0.000
W55.58 Bitten or struck by other mammals; Trade and service area;While engaged in other specified activities	0.002	0.998	0.000
W55.99 Bitten or struck by other mammals: Unspecified place: During unspecified activity	0.002	0.998	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.002	0.998	0.000
R25.2 Cramp and spasm	0.002	0.998	0.000
N84.1 Polyp of cervix uteri	0.002	0.998	0.000
N00.9 Unspecified	0.002	0.998	0.000
N00.8 Other	0.002	0.998	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N00.6 Dense deposit disease	0.002	0.998	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N00.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N00.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N00.0 Minor glomerular abnormality	0.002	0.998	0.000
N01.9 Unspecified	0.002	0.998	0.000
N01.8 Other	0.002	0.998	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N01.6 Dense deposit disease	0.002	0.998	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N01.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N01.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N01.0 Minor glomerular abnormality	0.002	0.998	0.000
N06.9 Unspecified	0.002	0.998	0.000
N06.8 Other	0.002	0.998	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N06.6 Dense deposit disease	0.002	0.998	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N06.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N06.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N06.0 Minor glomerular abnormality	0.002	0.998	0.000
N07.9 Unspecified	0.002	0.998	0.000
N07.8 Other	0.002	0.998	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N07.6 Dense deposit disease	0.002	0.998	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N07.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N07.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N07.0 Minor glomerular abnormality	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
H36.0 Diabetic retinopathy	0.002	0.998	0.000
H90.5 Sensorineural hearing loss, unspecified	0.000	0.998	0.002
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
Z03.5 Observation for other suspected cardiovascular diseases	0.002	0.998	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
H44.0 Purulent endophthalmitis	0.002	0.998	0.000
I27 Other pulmonary heart diseases	0.002	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
L72.2 Steatocystoma multiplex	0.000	0.998	0.002
N02.8 Other	0.002	0.998	0.000
N39.8 Other specified disorders of urinary system	0.000	0.998	0.002
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.002	0.998	0.000
I27.8 Other specified pulmonary heart diseases	0.002	0.998	0.000
X41.9 Unspecified place	0.002	0.998	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.002	0.998	0.000
H90.0 Conductive hearing loss, bilateral	0.000	0.998	0.002
I27.9 Pulmonary heart disease, unspecified	0.002	0.998	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.002	0.998	0.000
H44.2 Degenerative myopia	0.002	0.998	0.000
J35.0 Chronic tonsillitis	0.002	0.998	0.000
H44 Disorders of globe	0.002	0.998	0.000
R25 Abnormal involuntary movements	0.002	0.998	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.002	0.998	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.002	0.998	0.000
H44.5 Degenerated conditions of globe	0.002	0.998	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.002	0.998	0.000
W50.9 Unspecified place	0.002	0.998	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.002	0.998	0.000
D21.0 Connective and other soft tissue of head, face and neck	0.002	0.998	0.000
G71.0 Muscular dystrophy	0.000	0.998	0.002
H90 Conductive and sensorineural hearing loss	0.000	0.998	0.002
W64 Exposure to other and unspecified animate mechanical forces	0.002	0.998	0.000
W59 Bitten or crushed by other reptiles	0.002	0.998	0.000
W58 Bitten or struck by crocodile or alligator	0.002	0.998	0.000
W56 Contact with marine animal	0.002	0.998	0.000
W54 Bitten or struck by dog	0.002	0.998	0.000
W53 Bitten by rat	0.002	0.998	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.002	0.998	0.000
H90.3 Sensorineural hearing loss, bilateral	0.000	0.998	0.002
R22.2 Localised swelling, mass and lump, trunk	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.002	0.998	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.002	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
I27.1 Kyphoscoliotic heart disease	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
M41.99 Scoliosis, unspecified (Site unspecified)	0.002	0.998	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.002	0.998	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.998	0.002
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.998	0.002
W57.0 Home	0.002	0.998	0.000
W60.0 Home	0.002	0.998	0.000
N03 Chronic nephritic syndrome	0.002	0.998	0.000
H44.9 Disorder of globe, unspecified	0.002	0.998	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
W51 Striking against or bumped into by another person	0.002	0.998	0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
F02 Dementia in other diseases classified elsewhere	0.002	0.998	0.000
W50.3 Sports and athletics area	0.002	0.998	0.000
W50.8 Other specified place	0.002	0.998	0.000
W50.7 Farm	0.002	0.998	0.000
W50.6 Industrial and construction area	0.002	0.998	0.000
W50.5 Trade and service area	0.002	0.998	0.000
W50.4 Street and highway	0.002	0.998	0.000
W50.2 School, other institution and public administrative area	0.002	0.998	0.000
W50.1 Residential institution	0.002	0.998	0.000
W50.0 Home	0.002	0.998	0.000
R25.3 Fasciculation	0.002	0.998	0.000
R44.3 Hallucinations, unspecified	0.002	0.998	0.000
H44.8 Other disorders of globe	0.002	0.998	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.002	0.998	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.002	0.998	0.000
H44.3 Other degenerative disorders of globe	0.002	0.998	0.000
R25.0 Abnormal head movements	0.002	0.998	0.000
W57.9 Unspecified place	0.002	0.998	0.000
W57.7 Farm	0.002	0.998	0.000
W57.6 Industrial and construction area	0.002	0.998	0.000
W57.5 Trade and service area	0.002	0.998	0.000
W57.4 Street and highway	0.002	0.998	0.000
W57.3 Sports and athletics area	0.002	0.998	0.000
W57.2 School, other institution and public administrative area	0.002	0.998	0.000
W57.1 Residential institution	0.002	0.998	0.000
W60.9 Unspecified place	0.002	0.998	0.000
W60.8 Other specified place	0.002	0.998	0.000
W60.7 Farm	0.002	0.998	0.000
W60.6 Industrial and construction area	0.002	0.998	0.000
W60.5 Trade and service area	0.002	0.998	0.000
W60.4 Street and highway	0.002	0.998	0.000
W60.3 Sports and athletics area	0.002	0.998	0.000
W60.2 School, other institution and public administrative area	0.002	0.998	0.000
W60.1 Residential institution	0.002	0.998	0.000
Z30.3 Menstrual extraction	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.002	0.998	0.000
H44.1 Other endophthalmitis	0.002	0.998	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.002	0.998	0.000
W57.8 Other specified place	0.002	0.998	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.998	0.002
L65.9 Nonscarring hair loss, unspecified	0.002	0.998	0.000
R22.7 Localised swelling, mass and lump, multiple sites	0.002	0.998	0.000
C90.0 Multiple myeloma	0.000	0.998	0.002
E83.5 Disorders of calcium metabolism	0.000	0.998	0.002
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.000	0.998	0.002
N63 Unspecified lump in breast	0.002	0.998	0.000
H44.4 Hypotony of eye	0.002	0.998	0.000
M65.8 Other synovitis and tenosynovitis	0.002	0.998	0.000
W52.9 Unspecified place	0.001	0.998	0.000
W52.8 Other specified place	0.001	0.998	0.000
W52.7 Farm	0.001	0.998	0.000
W52.6 Industrial and construction area	0.001	0.998	0.000
W52.5 Trade and service area	0.001	0.998	0.000
W52.4 Street and highway	0.001	0.998	0.000
W52.3 Sports and athletics area	0.001	0.998	0.000
W52.2 School, other institution and public administrative area	0.001	0.998	0.000
W52.1 Residential institution	0.001	0.998	0.000
W52.0 Home	0.001	0.998	0.000
W53.9 Unspecified place	0.001	0.998	0.000
W53.8 Other specified place	0.001	0.998	0.000
W53.7 Farm	0.001	0.998	0.000
W53.6 Industrial and construction area	0.001	0.998	0.000
W53.5 Trade and service area	0.001	0.998	0.000
W53.4 Street and highway	0.001	0.998	0.000
W53.3 Sports and athletics area	0.001	0.998	0.000
W53.2 School, other institution and public administrative area	0.001	0.998	0.000
W53.1 Residential institution	0.001	0.998	0.000
W53.0 Home	0.001	0.998	0.000
W54.9 Unspecified place	0.001	0.998	0.000
W54.8 Other specified place	0.001	0.998	0.000
W54.4 Street and highway	0.001	0.998	0.000
W54.0 Home	0.001	0.998	0.000
W54.7 Farm	0.001	0.998	0.000
W54.6 Industrial and construction area	0.001	0.998	0.000
W54.5 Trade and service area	0.001	0.998	0.000
W54.3 Sports and athletics area	0.001	0.998	0.000
W54.2 School, other institution and public administrative area	0.001	0.998	0.000
W54.1 Residential institution	0.001	0.998	0.000
W56.9 Unspecified place	0.001	0.998	0.000
W56.8 Other specified place	0.001	0.998	0.000
W56.7 Farm	0.001	0.998	0.000
W56.6 Industrial and construction area	0.001	0.998	0.000
W56.5 Trade and service area	0.001	0.998	0.000
W56.4 Street and highway	0.001	0.998	0.000
W56.3 Sports and athletics area	0.001	0.998	0.000
W56.2 School, other institution and public administrative area	0.001	0.998	0.000
W56.1 Residential institution	0.001	0.998	0.000
W56.0 Home	0.001	0.998	0.000
W58.9 Unspecified place	0.001	0.998	0.000
W58.8 Other specified place	0.001	0.998	0.000
W58.7 Farm	0.001	0.998	0.000
W58.6 Industrial and construction area	0.001	0.998	0.000
W58.5 Trade and service area	0.001	0.998	0.000
W58.4 Street and highway	0.001	0.998	0.000
W58.3 Sports and athletics area	0.001	0.998	0.000
W58.2 School, other institution and public administrative area	0.001	0.998	0.000
W58.1 Residential institution	0.001	0.998	0.000
W58.0 Home	0.001	0.998	0.000
W59.9 Unspecified place	0.001	0.998	0.000
W59.8 Other specified place	0.001	0.998	0.000
W59.7 Farm	0.001	0.998	0.000
W59.6 Industrial and construction area	0.001	0.998	0.000
W59.5 Trade and service area	0.001	0.998	0.000
W59.4 Street and highway	0.001	0.998	0.000
W59.3 Sports and athletics area	0.001	0.998	0.000
W59.2 School, other institution and public administrative area	0.001	0.998	0.000
W59.1 Residential institution	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations